| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Department of Pathology and Laboratory Medicine,* Epithelial Pathobiology Unit, Emory University School of Medicine, Atlanta, Georgia; and the Gut Immunology Group,
Rowett Research Institute, Bucksburn, Aberdeen, United Kingdom
Flagellin, the primary component of bacterial flagella, is a potent activator of toll-like receptor 5 (TLR5) signaling and is a major proinflammatory determinant of enteropathogenic Salmonella. In accordance with this, we report here that aflagellate Salmonella mutants are impaired in their ability to up-regulate proinflammatory and anti-apoptotic effector molecules in murine models of salmonellosis and that these mutants elicit markedly reduced early mucosal inflammation relative to their isogenic parent strains. Conversely, aflagellate bacteria were more potent activators of epithelial caspases and subsequent apoptosis. These phenomena correlated with a delayed but markedly exacerbated mucosal inflammation at the later stages of infection as well as elevated extra-intestinal and systemic bacterial load, culminating in a more severe clinical outcome. Systemic administration of exogenous flagellin primarily reversed the deleterious effects of in vivo Salmonella infection. These observations indicate that in Salmonella infection, flagellin plays a dominant role in activation of not only innate immunity but also anti-apoptotic processes in epithelial cells. These latter TLR-mediated responses that delay epithelial apoptosis may be as critical to mucosal defense as the classic acute inflammatory response. This notion is consistent with the emerging paradigm that specific TLR ligands may have a fundamental cytoprotective effect during inflammatory stress.
This article has been cited by other articles:
![]() |
M. Vijay-Kumar, J. D. Aitken, C. J. Sanders, A. Frias, V. M. Sloane, J. Xu, A. S. Neish, M. Rojas, and A. T. Gewirtz Flagellin Treatment Protects against Chemicals, Bacteria, Viruses, and Radiation J. Immunol., June 15, 2008; 180(12): 8280 - 8285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vijay-Kumar, J. D. Aitken, A. Kumar, A. S. Neish, S. Uematsu, S. Akira, and A. T. Gewirtz Toll-Like Receptor 5-Deficient Mice Have Dysregulated Intestinal Gene Expression and Nonspecific Resistance to Salmonella-Induced Typhoid-Like Disease Infect. Immun., March 1, 2008; 76(3): 1276 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, L. D. Hazlett, and F.-S. X. Yu Flagellin Suppresses the Inflammatory Response and Enhances Bacterial Clearance in a Murine Model of Pseudomonas aeruginosa Keratitis Infect. Immun., January 1, 2008; 76(1): 89 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Sun, H. G. Rolan, and R. M. Tsolis Injection of Flagellin into the Host Cell Cytosol by Salmonella enterica Serotype Typhimurium J. Biol. Chem., November 23, 2007; 282(47): 33897 - 33901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, J. Yin, J. Zhang, and F.-S. X. Yu Modulation of Corneal Epithelial Innate Immune Response to Pseudomonas Infection by Flagellin Pretreatment Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4664 - 4670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saha, F. Takeshita, T. Matsuda, N. Jounai, K. Kobiyama, T. Matsumoto, S. Sasaki, A. Yoshida, K.-Q. Xin, D. M. Klinman, et al. Blocking of the TLR5 Activation Domain Hampers Protective Potential of Flagellin DNA Vaccine J. Immunol., July 15, 2007; 179(2): 1147 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Lebeis, B. Bommarius, C. A. Parkos, M. A. Sherman, and D. Kalman TLR Signaling Mediated by MyD88 Is Required for a Protective Innate Immune Response by Neutrophils to Citrobacter rodentium J. Immunol., July 1, 2007; 179(1): 566 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Adriaensen, H. De Greve, J. Q. Tian, S. De Craeye, E. Gubbels, V. Eeckhaut, F. Van Immerseel, R. Ducatelle, M. Kumar, and J.-P. Hernalsteens A Live Salmonella enterica Serovar Enteritidis Vaccine Allows Serological Differentiation between Vaccinated and Infected Animals Infect. Immun., May 1, 2007; 75(5): 2461 - 2468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |